
Sign up to save your podcasts
Or


Send us Fan Mail
In this episode, we break down Sai Life Sciences, the fourth company in our 20 Unique Businesses series, where we explore high-quality companies with strong competitive advantages.
Sai Life Sciences is a unique CRDMO player in the pharma sector that earns 100% of its revenue from global innovator companies like Pfizer and AbbVie.
We explain how the CDMO and CRO industry works, why integration from research to manufacturing is a powerful business model, and how this company stands out from others in the space.
We also cover industry growth, business segments, key molecules, growth triggers, and risks, giving you a clear and simple understanding of this business.
By SOICSend us Fan Mail
In this episode, we break down Sai Life Sciences, the fourth company in our 20 Unique Businesses series, where we explore high-quality companies with strong competitive advantages.
Sai Life Sciences is a unique CRDMO player in the pharma sector that earns 100% of its revenue from global innovator companies like Pfizer and AbbVie.
We explain how the CDMO and CRO industry works, why integration from research to manufacturing is a powerful business model, and how this company stands out from others in the space.
We also cover industry growth, business segments, key molecules, growth triggers, and risks, giving you a clear and simple understanding of this business.